The rapid adoption of telemedicine is one of the few positive developments of the COVID-19 pandemic, writes fellow Katharine Neill Harris. She explains why the DEA’s recent proposal to change the rules for prescribing drugs via telemedicine would harm patients and increase demand for and exposure to unregulated and more dangerous drugs.
Methane emissions are both "extraordinarily bad" and "easy to fix," so why not address them now? A federal tax of $1,500 per metric ton emitted could curb and counter the impact of U.S. methane emissions, argues this commentary piece.
Despite the Trump administration sentiment that the U.S. partner with Saudi Arabia in a joint oil alliance, such an approach is unlikely to be successful, write energy fellows Jim Krane and Mark Finley. Forbes blog: https://bit.ly/2WUa6rb
Fellow Katharine Neill Harris considers the validity of risk assessment tools, which estimate the likelihood that an individual who has been charged with or convicted of a crime will commit a future offense. Baker Institute Blog: https://bit.ly/2Cwl6jc
Body-worn cameras (BWCs) are becoming a permanent fixture of modern policing, and their effects are likely to be much more nuanced than originally predicted.
"With the U.S. and Iran staggering toward war, it bears asking: How would U.S. interests be served by war with Iran?" writes fellow Jim Krane. Read his argument for why U.S. interests would be deeply undermined by any such war on the Baker Institute Blog.
This post originally appeared in the Forbes Blog on June 17, 2019.
The Commission on Combatting Drug Addiction and the Opioid Crisis appointed by President Trump released its report on Monday, July 31. Drug policy fellow Katharine Neill Harris assesses the commission's recommendations in the Baker Institute Blog.
Drug policy fellow Katharine A. Neill explains why establishing heroin-assisted treatment programs, which provide severely addicted individuals with controlled access to pharmaceutical-grade heroin, could make a significant dent in the number of U.S. deaths from opioid use in this post for the Baker Institute Blog.
Katharine Neill, the Alfred C. Glassell, III Postdoctoral Fellow in Drug Policy, explains what you should know about the Justice Department's plan to release 6,000 nonviolent drug offenders from federal prison during four days in October and November.